These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30502611)

  • 1. Natalizumab exposure during pregnancy in multiple sclerosis: a systematic review.
    Peng A; Qiu X; Zhang L; Zhu X; He S; Lai W; Chen L
    J Neurol Sci; 2019 Jan; 396():202-205. PubMed ID: 30502611
    [No Abstract]   [Full Text] [Related]  

  • 2. Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks.
    Portaccio E; Annovazzi P; Ghezzi A; Zaffaroni M; Moiola L; Martinelli V; Lanzillo R; Brescia Morra V; Rinaldi F; Gallo P; Tortorella C; Paolicelli D; Pozzilli C; De Giglio L; Cavalla P; Cocco E; Marrosu MG; Patti F; Solaro C; Bellantonio P; Uccelli A; Laroni A; Pastò L; Giannini M; Trojano M; Comi G; Amato MP;
    Neurology; 2018 Mar; 90(10):e823-e831. PubMed ID: 29438046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Disease modifying drugs in multiple sclerosis and pregnancy].
    Tur C; Tintoré M; Aguilera C
    Med Clin (Barc); 2012 Sep; 139(7):316-8. PubMed ID: 22743277
    [No Abstract]   [Full Text] [Related]  

  • 4. How safe is natalizumab during pregnancy?
    Duquette P; Prat A
    Mult Scler; 2015 Feb; 21(2):121-2. PubMed ID: 25392323
    [No Abstract]   [Full Text] [Related]  

  • 5. Exposure to natalizumab during pregnancy and lactation is safe - No.
    Airas L
    Mult Scler; 2020 Jul; 26(8):889-891. PubMed ID: 32508200
    [No Abstract]   [Full Text] [Related]  

  • 6. Exposure to natalizumab during pregnancy and lactation is safe - Yes.
    Landi D; Marfia GA
    Mult Scler; 2020 Jul; 26(8):887-889. PubMed ID: 32508253
    [No Abstract]   [Full Text] [Related]  

  • 7. Localized sporotrichosis during natalizumab treatment in Multiple Sclerosis.
    Marques PT; Kay CSK; Basílio FMA; Pinheiro RL; Werneck LC; Lorenzoni PJ; Scola RH
    Mult Scler Relat Disord; 2020 Jun; 41():102029. PubMed ID: 32155462
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclical suicidal ideation following natalizumab infusion for multiple sclerosis.
    Nagesh O; Bastiampillai T; Fisher L; Mohan T
    Aust N Z J Psychiatry; 2015 Jul; 49(7):668-9. PubMed ID: 25688123
    [No Abstract]   [Full Text] [Related]  

  • 9. Myocardial infarction in a patient with multiple sclerosis after receiving natalizumab.
    Darki A; Masoumi P; Soleimani A; Naser Moghadasi A
    Mult Scler Relat Disord; 2018 Oct; 25():26-28. PubMed ID: 30025371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natalizumab: retinal necrosis.
    Prescrire Int; 2017 May; 26(182):124. PubMed ID: 30730671
    [No Abstract]   [Full Text] [Related]  

  • 11. Evolution of MRI appearances due to progressive multifocal leucoencephalopathy following natalizumab treatment for multiple sclerosis.
    Campbell S; Kanodia AK; O'Riordan J
    BMJ Case Rep; 2015 Apr; 2015():. PubMed ID: 25878241
    [No Abstract]   [Full Text] [Related]  

  • 12. Natalizumab for Multiple Sclerosis: A Case in Point for the Impact of Translational Neuroimmunology.
    Shirani A; Stüve O
    J Immunol; 2017 Feb; 198(4):1381-1386. PubMed ID: 28167648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PML in natalizumab-treated multiple sclerosis: Modeling errors and risk miscalculations.
    Mowry EM; McArthur JC
    Neurology; 2017 Mar; 88(12):1110-1111. PubMed ID: 28228562
    [No Abstract]   [Full Text] [Related]  

  • 14. Natalizumab induced cutaneous sarcoidosis-like reaction.
    Durcan R; Heffron C; Sweeney B
    J Neuroimmunol; 2019 Aug; 333():476955. PubMed ID: 31108403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive outer retinal necrosis in a multiple sclerosis patient on natalizumab.
    Bourre B; Gueudry J; Lefaucheur R; Borden A; Maltête D; Patel SS; Van Tassel SH; Gupta MP; Orlin A; Nealon NM
    Neurology; 2016 Jan; 86(3):312-3. PubMed ID: 26783270
    [No Abstract]   [Full Text] [Related]  

  • 16. [Natalizumab can induce progressive multifocal leucoencephalopathy].
    Theódórsdóttir A; Blaabjerg M; Falah M
    Ugeskr Laeger; 2014 Aug; 176(35):. PubMed ID: 25293706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical dysplasia in a patient with multiple sclerosis treated with natalizumab.
    Durrieu G; Dardonville Q; Clanet M; Montastruc JL
    Fundam Clin Pharmacol; 2019 Feb; 33(1):125-126. PubMed ID: 29935014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natalizumab concentrations during pregnancy in three patients with multiple sclerosis: A clinical commentary.
    Dobson R; Chung K
    Mult Scler; 2022 Feb; 28(2):326-327. PubMed ID: 35083940
    [No Abstract]   [Full Text] [Related]  

  • 19. Pregnancy outcomes amongst multiple sclerosis females with third trimester natalizumab use.
    Triplett JD; Vijayan S; Rajanayagam S; Tuch P; Kermode AG
    Mult Scler Relat Disord; 2020 May; 40():101961. PubMed ID: 32028118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dealing with highly active multiple sclerosis after natalizumab-associated PML: could rituximab be of help?
    Mancinelli CR; Scarpazza C; Santuccio G; De Rossi N; Capra R
    Neurol Sci; 2018 May; 39(5):965-966. PubMed ID: 29302813
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.